CSX vs IMA · P/E 19, rev $14.09B vs rev $9.2M
CSX Corporation (CSX) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CSX and IMA stock pages for the full models.
Not investment advice.